Nikolai Petrovsky, PhD
Research Director and Professor of Medicine, Vaxine Pty Ltd
Nikolai Petrovsky is Research Director of Vaxine, an Adelaide-based biotechnology company focused on vaccine development and Professor of Medicine at Flinders University. He is a clinical endocrinologist and has a PhD in immunology. His work in vaccines and artificial intelligence has been awarded over 50 million dollars in grants from the US National Institutes of Health. He has authored over 200 peer-reviewed research papers and is an inventor on multiple vaccine patents. He developed SpikoGen®, a vaccine against COVID-19 that in October 2021 received emergency use authorization in the Middle east, making it the first recombinant spike protein vaccine against Covid-19 in the world to achieve regulatory approval and the first novel approved human vaccine developed in Australia since the Q fever vaccine 40 years ago.